The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy.
about
The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The inhibitory checkpoint, PD- ...... sibilities for immune therapy.
@en
The inhibitory checkpoint, PD- ...... sibilities for immune therapy.
@nl
type
label
The inhibitory checkpoint, PD- ...... sibilities for immune therapy.
@en
The inhibitory checkpoint, PD- ...... sibilities for immune therapy.
@nl
prefLabel
The inhibitory checkpoint, PD- ...... sibilities for immune therapy.
@en
The inhibitory checkpoint, PD- ...... sibilities for immune therapy.
@nl
P2093
P2860
P50
P1433
P1476
The inhibitory checkpoint, PD- ...... ssibilities for immune therapy
@en
P2093
Evelina Martinenaite
Lars Munksgaard
Lars Møller Pedersen
Mia Aaboe Jørgensen
Niels Ødum
Shamaila Munir Ahmad
P2860
P304
P356
10.1080/2162402X.2017.1390641
P50
P577
2017-11-01T00:00:00Z